Navigation Links
National Hemophilia Foundation's (NHF) CEO Featured in Black Enterprise Magazine
Date:11/12/2008

NEW YORK, Nov. 12 /PRNewswire/ -- Val Bias, Chief Executive Officer of the National Hemophilia Foundation is featured in the November 2008 issue of Black Enterprise magazine in the "On the Move" section of the Powerplay Department. The department highlights African-American men and women who have been appointed to new management positions in the upper echelons of the corporate world. Recent announcements have included leadership posts at BET, MTV and Northrop Grumman.

Black Enterprise magazine is a monthly business publication for African-American professionals and entrepreneurs. It has a paid circulation of 525,000, with approximately 4.3 million readers. The magazine is available online at: http://www.blackenterprise.com.

Bias joined the National Hemophilia Foundation as Chief Executive Officer in May 2008 after the board searched for candidates that exemplified quality leadership in the bleeding and clotting disorders community. Mr. Bias is also the first African-American to serve as CEO in NHF's 50 year history.

A long history with NHF proves that Bias is a trusted leader, diplomatic manager and committed participant in the bleeding and clotting disorders community. For more than 28 years, he has served NHF as a volunteer, consultant, advocate and board chair in 1992.

In his position as CEO, Bias was immediately tasked with advancing a nationwide reorganization of the Foundation and the strategic positioning of the organization. Bias also promised to increase efforts on research and advocacy while using education as a key component.

Bias will be leading the NHF's 60th annual meeting in Denver, Colorado on November 13-15, 2008. The meeting is the largest in the country bringing together individuals and their families living with bleeding and clotting disorders -- healthcare providers -- community leaders and industry representatives.

"From an incredible base of candidates including aligned organization leaders, community advocates, associated sciences and businesses, Val Bias stood front and center as the best leader upon whom NHF and its constituents may solidly depend to lead this organization into the future," said Raymond Stanhope, Chair of the Board of Directors for the National Hemophilia Foundation. "Vision, dedication, clarity of purpose -- Val brings it all."

About Hemophilia

Approximately 400,000 people around the world have hemophilia. Hemophilia is an inherited bleeding disorder characterized by prolonged or spontaneous bleeding, especially into the muscles, joints, or internal organs. The disease is caused by deficient or defective blood coagulation proteins, known as factor VIII or IX. The most common form of the disease is hemophilia A, or classic hemophilia, in which the clotting factor VIII is either deficient or defective. Hemophilia B is characterized by deficient or defective factor IX.

About the National Hemophilia Foundation

The National Hemophilia Foundation is dedicated to finding better treatments and cures for bleeding and clotting disorders and to preventing the complications of these disorders through education, advocacy and research.


'/>"/>
SOURCE National Hemophilia Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. November: National Epilepsy Awareness Month Actress Hunter Tylo Turns Tragic Loss Into Hope
2. Nationally Recognized Diabetes Specialist Dr. Steven Edelman to Provide Educational Articles on Diabetes to MyCareTeam's Website Community
3. Medicare Today Launches National Medicare Prescription Drug Enrollment Awareness Campaign
4. Lilly Announces Major Donation of Insulin to International Diabetes Federations Life for a Child Program; Initial Focus Will Be on Sub-Saharan Africa
5. Video: CVS/pharmacy and National Council on Aging Help Seniors to Find the Right Prescription for Medicare Savings
6. InfoLogix CEO to Address Hidden Value of ID Technology at International Conference
7. Anpath Group, Inc. Expands International Distribution With Minntech Corporation
8. Hydron Technologies, Inc. and Brand Builders International, LLC Join Forces to Form New Entity
9. National Health High Risk Pool Association Available to Discuss Role of Pools in President Elect Obamas Health Care Reform Plans
10. Anthem Blue Cross and Blue Shield in Maine Among Top Insurers on U.S. News & World Report/National Committee for Quality Assurance Americas Best Health Plans List
11. Long Term Care International Forum names LTCGs Pam Kreager as President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 24, 2017 , ... The health insurance industry is ... (AEP) and the Open Enrollment Period (OEP). 2016 was no exception. If anything, ... witnessing higher deductibles, rising premiums, and few choices with their insurance, which is ...
(Date:1/24/2017)... ... , ... The Cruise Web Inc. was recognized today as Northeast ... Annual MSC True Partnerships’ Awards. , The 2016 MSC True Partnerships Awards are ... on overall business growth in revenue and guests and continuous partnership support and innovative ...
(Date:1/24/2017)... ... January 24, 2017 , ... OMI Industries, a worldwide leader ... distribution partnership with Byers Scientific & Manufacturing , a leading designer, engineer ... agreement, OMI Industries formulated a special version of Ecosorb® for Byers Scientific & ...
(Date:1/24/2017)... Hill, N.C. (PRWEB) , ... January 24, 2017 ... ... Trump Administration is the focus of a new report from the Frank ... Kenan-Flagler Business School. , Influential business leaders, academics and policy makers identified concrete ...
(Date:1/24/2017)... ... January 24, 2017 , ... Date aired: January 23, 2017 ... the nation’s foremost water advocate and host of the nationally syndicated The Sharon ... America, once again welcomed one of her favorite guests and colleagues, Dr. Gerald ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... Md. , Jan. 24, 2017   Intrexon Corporation ... engineering and industrialization of biology to improve the quality of ... has entered into a definitive agreement to acquire GenVec, ... and pioneer in the development of AdenoVerse™ gene delivery technology.  ... GenVec,s expertise in adenoviral vectors and cGMP drug product manufacturing ...
(Date:1/24/2017)... , Jan. 24, 2017   QR ... biopharmaceutical company developing novel therapies for the treatment ... announced the appointment of four world-class key opinion ... new appointments join QR Pharma,s previous roster of ... and direction to support the development of the ...
(Date:1/24/2017)... Research and Markets has announced the addition of the "Optogenetics ... report to their offering. ... Global Optogenetics Market is poised to grow at ... approximately $76.24 million by 2025. Some of the prominent ... using optogentic techniques for neurosciences, quick growth ultrafast laser tools technology, ...
Breaking Medicine Technology: